Biblio Discovery — Demo Discovery Service

4 hasil untuk "Simon Cockell"

Menampilkan 1–4 · 0,60 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

    Olivier Govaere; Simon Cockell; DINA G. TINIAKOS dkk.

    Science Translational Medicine · 2020 · Inggris · OpenAlex Scopus

    , whereas GDF15 supplementation tempered the inflammatory response in macrophages upon lipid loading and lipopolysaccharide stimulation. This study provides insights into the pathophysiology of progressive fibrosing steatohepatitis, and proof of principle that transcriptomic changes represent…

  2. Artikel Jurnal Teks lengkap

    Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

    Quentin Mark Anstee; Rebecca Darlay; Simon Cockell dkk.

    Journal of Hepatology · 2020 · Inggris · OpenAlex Scopus

    Background & Aims Genetic factors associated with non-alcoholic fatty liver disease (NAFLD) remain incompletely understood. To date, most genome-wide association studies (GWASs) have adopted radiologically assessed hepatic triglyceride content as the reference phenotype and so cannot address…

  3. Artikel Jurnal Teks lengkap

    NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    Dominik Reinhard Pfister; Nicolás Gonzalo Núñez; Roser Pinyol dkk.

    Nature · 2021 · Inggris · OpenAlex Scopus

    Abstract Hepatocellular carcinoma (HCC) can have viral or non-viral causes 1–5 . Non-alcoholic steatohepatitis (NASH) is an important driver of HCC. Immunotherapy has been approved for treating HCC, but biomarker-based stratification of patients for optimal response to therapy is an unmet need 6,7…

  4. Artikel Jurnal Teks lengkap

    An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

    Michèle Vacca; Ioannis Kamzolas; Lea Mørch Harder dkk.

    Nature Metabolism · 2024 · Inggris · OpenAlex Scopus

    Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease, encompasses steatosis and metabolic dysfunction-associated steatohepatitis (MASH), leading to cirrhosis and hepatocellular carcinoma. Preclinical MASLD research is mainly…